POLYMYXIN B

POLYMYXIN B was reported 1860 times

POLYMYXIN B is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC HYPOPERFUSION 1 0.1429
1 PHLYCTENULAR KERATOCONJUNCTIVITIS 1 0.1000
2 CONJUNCTIVAL RETRACTION 1 0.0625
3 BARREL CHEST 1 0.0526
4 RESPIRATORY PARALYSIS 8 0.0500
5 LARYNGEAL TREMOR 1 0.0476
6 NECROTISING GASTRITIS 1 0.0312
7 CHOLANGITIS INFECTIVE 7 0.0263
8 DISSEMINATED SPOROTRICHOSIS 1 0.0263
9 FLAVOBACTERIUM INFECTION 1 0.0227
10 TRICHOSPORON INFECTION 9 0.0222
11 NEURILEMMOMA BENIGN 1 0.0208
12 MESENTERIC LYMPHADENITIS 1 0.0192
13 PSEUDO-BARTTER SYNDROME 2 0.0192
14 INFECTION PROTOZOAL 1 0.0175
15 POST PROCEDURAL OEDEMA 4 0.0172
16 VULVOVAGINAL DISORDER 1 0.0164
17 AEROMONAS INFECTION 3 0.0159
18 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 1 0.0145
19 PTERYGIUM 5 0.0145
20 CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER 1 0.0139
21 CEREBRAL VENTRICLE COLLAPSE 1 0.0133
22 BACTERIAL TRANSLOCATION 4 0.0126
23 PERIPHERAL VEIN THROMBOSIS 3 0.0126
24 HYPOPHARYNGEAL CANCER 1 0.0119
25 SUPERINFECTION FUNGAL 1 0.0118
26 SCHISTOCYTOSIS 1 0.0115
27 VIRAL HEPATITIS CARRIER 1 0.0114
28 HUMAN BOCAVIRUS INFECTION 2 0.0106
29 SPOROTRICHOSIS 1 0.0101
30 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
31 NEUROMUSCULAR BLOCKADE 2 0.0089
32 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 2 0.0089
33 URATE NEPHROPATHY 1 0.0086
34 PERINEAL DISORDER 1 0.0083
35 CONJUNCTIVAL EROSION 1 0.0083
36 PERIANAL ERYTHEMA 1 0.0083
37 TRACHEOSTOMY INFECTION 1 0.0082
38 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
39 PNEUMONIA ACINETOBACTER 1 0.0073
40 TRAUMATIC HAEMOTHORAX 2 0.0072
41 CSF CELL COUNT INCREASED 1 0.0068
42 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
43 DYSBIOSIS 5 0.0061
44 VARICELLA VIRUS TEST POSITIVE 1 0.0059
45 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
46 ACCELERATED HYPERTENSION 2 0.0053
47 URINARY TRACT CANDIDIASIS 1 0.0052
48 GENITAL TRACT INFLAMMATION 1 0.0050
49 DIAPHRAGMATIC PARALYSIS 3 0.0050
50 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
51 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
52 KLEBSIELLA TEST POSITIVE 3 0.0046
53 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
54 DRUG CLEARANCE INCREASED 1 0.0045
55 ILIOTIBIAL BAND SYNDROME 1 0.0044
56 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
57 SJS-TEN OVERLAP 3 0.0043
58 GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
59 VENTRICULAR HYPOPLASIA 1 0.0040
60 PNEUMOMEDIASTINUM 7 0.0039
61 BACTEROIDES INFECTION 1 0.0038
62 SYMBLEPHARON 1 0.0038
63 HERPES ZOSTER REACTIVATION 1 0.0038
64 HERPES ZOSTER DISSEMINATED 3 0.0037
65 ACINETOBACTER INFECTION 4 0.0037
66 BLOOD CHOLINESTERASE DECREASED 1 0.0036
67 VENTILATION PERFUSION MISMATCH 1 0.0036
68 VULVOVAGINITIS 1 0.0034
69 PATHOGEN RESISTANCE 31 0.0034
70 TISSUE INFILTRATION 1 0.0034
71 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
72 VAGINAL FLATULENCE 1 0.0033
73 ELECTROCARDIOGRAM QT SHORTENED 1 0.0033
74 HEPATIC ISCHAEMIA 1 0.0032
75 RETROPERITONEAL ABSCESS 1 0.0032
76 VOCAL CORD THICKENING 1 0.0031
77 VAGINAL CANCER 1 0.0031
78 HAEMATOLOGY TEST ABNORMAL 1 0.0031
79 MYCOBACTERIUM MARINUM INFECTION 1 0.0031
80 CELLULITE 1 0.0031
81 CAROTID ARTERY ANEURYSM 1 0.0029
82 KLEBSIELLA SEPSIS 3 0.0027
83 VANCOMYCIN INFUSION REACTION 1 0.0027
84 INSTILLATION SITE PRURITUS 1 0.0027
85 HYDROURETER 1 0.0026
86 BLOOD FIBRINOGEN DECREASED 3 0.0026
87 COAGULATION TEST ABNORMAL 2 0.0026
88 EYE INFECTION FUNGAL 1 0.0026
89 KLEBSIELLA INFECTION 13 0.0026
90 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
91 DEPENDENCE ON RESPIRATOR 1 0.0025
92 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
93 LYMPHOCYTIC LEUKAEMIA 1 0.0025
94 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
95 MUSCLE STRENGTH ABNORMAL 1 0.0024
96 JOINT SURGERY 1 0.0023
97 PULMONARY VALVE STENOSIS CONGENITAL 1 0.0023
98 VITAL CAPACITY DECREASED 1 0.0022
99 VASOSPASM 2 0.0022
100 PNEUMONIA KLEBSIELLA 4 0.0022
101 PULMONARY VASCULAR DISORDER 1 0.0021
102 BLOOD BICARBONATE INCREASED 1 0.0021
103 HYPERSPLENISM 1 0.0020
104 GENITAL ERYTHEMA 1 0.0020
105 MUSCLE HAEMORRHAGE 8 0.0020
106 TRACHEAL DISORDER 1 0.0019
107 GASTRIC ANTRAL VASCULAR ECTASIA 1 0.0019
108 INADEQUATE DIET 1 0.0019
109 HYPERAMYLASAEMIA 1 0.0018
110 MILK ALLERGY 1 0.0018
111 VANISHING BILE DUCT SYNDROME 2 0.0018
112 RENAL TUBULAR DYSFUNCTION 1 0.0018
113 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
114 GRAFT COMPLICATION 1 0.0017
115 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
116 RENAL TUBULAR INJURY 2 0.0016
117 DRUG RESISTANCE 42 0.0016
118 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
119 MACULAR DEGENERATION 19 0.0016
120 BACILLUS INFECTION 1 0.0016
121 NECROTISING COLITIS 2 0.0016
122 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
123 CORNEAL ABRASION 2 0.0015
124 GLASSY EYES 1 0.0014
125 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
126 SKIN HYPERPIGMENTATION 12 0.0014
127 PROTEUS INFECTION 1 0.0014
128 ANTIBODY TEST ABNORMAL 1 0.0014
129 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
130 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
131 MYASTHENIA GRAVIS CRISIS 2 0.0013
132 CHOLESTATIC LIVER INJURY 3 0.0013
133 ARTERIAL INJURY 1 0.0013
134 HEART SOUNDS ABNORMAL 1 0.0013
135 TRACHEOBRONCHITIS 1 0.0013
136 ARTERIAL RUPTURE 1 0.0013
137 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
138 URETERIC STENOSIS 1 0.0012
139 METABOLIC ALKALOSIS 2 0.0012
140 FUNGAL SEPSIS 1 0.0012
141 SEPTIC EMBOLUS 1 0.0012
142 LUNG OPERATION 1 0.0012
143 BLOOD PH DECREASED 2 0.0012
144 TONGUE MOVEMENT DISTURBANCE 1 0.0012
145 RETINITIS 2 0.0012
146 CARDIAC OUTPUT DECREASED 1 0.0011
147 JUGULAR VEIN THROMBOSIS 2 0.0011
148 DRUG DETOXIFICATION 1 0.0011
149 HYPERLACTACIDAEMIA 3 0.0011
150 NUCHAL RIGIDITY 1 0.0011
151 PUNCTATE KERATITIS 1 0.0011
152 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
153 KLEBSIELLA BACTERAEMIA 1 0.0011
154 COARCTATION OF THE AORTA 1 0.0010
155 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
156 HAEMOPHILUS INFECTION 1 0.0010
157 PYURIA 1 0.0010
158 GENE MUTATION 2 0.0010
159 EMPYEMA 2 0.0010
160 EYELID PAIN 2 0.0010
161 CAROTID ARTERIOSCLEROSIS 1 0.0010
162 MULTIPLE-DRUG RESISTANCE 3 0.0010
163 NEUTROPENIC COLITIS 2 0.0010
164 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
165 HEART TRANSPLANT REJECTION 1 0.0010
166 IRIDOCYCLITIS 3 0.0009
167 BONE DEMINERALISATION 1 0.0009
168 BLOOD SODIUM ABNORMAL 1 0.0009
169 BACTERIAL SEPSIS 3 0.0009
170 INSTILLATION SITE REACTION 1 0.0009
171 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
172 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
173 CARBON DIOXIDE DECREASED 1 0.0009
174 PROCALCITONIN INCREASED 1 0.0009
175 NECROTISING FASCIITIS 3 0.0009
176 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
177 CONJUNCTIVAL HYPERAEMIA 3 0.0008
178 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
179 EYELID SKIN DRYNESS 1 0.0008
180 FEBRILE CONVULSION 1 0.0008
181 TOOTH EROSION 1 0.0008
182 NEPHROPATHY TOXIC 9 0.0008
183 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
184 WHITE MATTER LESION 1 0.0008
185 URINARY TRACT INFECTION BACTERIAL 2 0.0008
186 TROPONIN T INCREASED 1 0.0008
187 SLOW RESPONSE TO STIMULI 1 0.0008
188 ACQUIRED GENE MUTATION 1 0.0008
189 NEUROTOXICITY 13 0.0007
190 GLYCOSURIA 1 0.0007
191 CARBON DIOXIDE INCREASED 1 0.0007
192 EFFUSION 1 0.0007
193 MUCOUS MEMBRANE DISORDER 1 0.0007
194 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
195 RENAL TUBULAR DISORDER 2 0.0007
196 HYPERPYREXIA 3 0.0007
197 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
198 MENINGITIS BACTERIAL 1 0.0007
199 INJECTION SITE HYPOAESTHESIA 1 0.0007
200 PELVIC VENOUS THROMBOSIS 1 0.0007
201 ADENOVIRUS INFECTION 2 0.0007
202 PULMONARY SEPSIS 1 0.0007
203 PULMONARY VALVE INCOMPETENCE 1 0.0007
204 PANCREATIC ENZYMES INCREASED 1 0.0007
205 PNEUMONIA PNEUMOCOCCAL 1 0.0007
206 KNEE DEFORMITY 1 0.0007
207 ADHESION 1 0.0007
208 CYTOMEGALOVIRUS INFECTION 11 0.0007
209 MEAN CELL VOLUME DECREASED 1 0.0006
210 OSTEOMALACIA 1 0.0006
211 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
212 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
213 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
214 INHIBITORY DRUG INTERACTION 1 0.0006
215 PHARYNGEAL PARAESTHESIA 1 0.0006
216 ENTERITIS 4 0.0006
217 RASH VESICULAR 3 0.0006
218 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
219 SPINAL DEFORMITY 1 0.0006
220 FEMALE GENITAL TRACT FISTULA 1 0.0006
221 MILIARIA 1 0.0006
222 BLOOD CHLORIDE INCREASED 1 0.0006
223 BLOOD CREATININE ABNORMAL 2 0.0006
224 FANCONI SYNDROME ACQUIRED 1 0.0006
225 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
226 TRANSPLANT DYSFUNCTION 1 0.0006
227 ESSENTIAL HYPERTENSION 1 0.0005
228 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
229 PNEUMONIA BACTERIAL 5 0.0005
230 CYSTIC FIBROSIS 3 0.0005
231 GASTRIC ULCER HAEMORRHAGE 3 0.0005
232 BLOOD BICARBONATE DECREASED 1 0.0005
233 HAEMOLYSIS 4 0.0005
234 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
235 APLASIA 1 0.0005
236 HYPERAEMIA 1 0.0005
237 ACUTE KIDNEY INJURY 77 0.0005
238 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
239 CYSTITIS HAEMORRHAGIC 2 0.0005
240 MYASTHENIA GRAVIS 4 0.0005
241 VENOUS THROMBOSIS LIMB 1 0.0005
242 BODY TEMPERATURE FLUCTUATION 1 0.0005
243 SLEEP DEFICIT 1 0.0005
244 TORTICOLLIS 1 0.0005
245 FOETAL DISTRESS SYNDROME 1 0.0005
246 SEPTIC SHOCK 20 0.0005
247 CORNEAL DISORDER 1 0.0005
248 LIMB MASS 1 0.0005
249 NOSOCOMIAL INFECTION 1 0.0005
250 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
251 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
252 PSEUDOMEMBRANOUS COLITIS 1 0.0004
253 LARGE INTESTINAL OBSTRUCTION 1 0.0004
254 MENINGITIS ASEPTIC 2 0.0004
255 SUSPECTED OFF LABEL USE 2 0.0004
256 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
257 BACTERIAL INFECTION 8 0.0004
258 NEPHROPATHY 4 0.0004
259 BILIRUBIN CONJUGATED INCREASED 1 0.0004
260 ORAL SURGERY 1 0.0004
261 ATAXIA 5 0.0004
262 URINE FLOW DECREASED 1 0.0004
263 KIDNEY TRANSPLANT REJECTION 2 0.0004
264 ENTEROCOCCAL INFECTION 2 0.0004
265 TREATMENT FAILURE 34 0.0004
266 GLOMERULONEPHRITIS 1 0.0004
267 TRANSPLANT FAILURE 1 0.0004
268 DERMAL CYST 1 0.0004
269 INFREQUENT BOWEL MOVEMENTS 1 0.0004
270 EOSINOPHILIA 7 0.0004
271 HYPERPARATHYROIDISM SECONDARY 1 0.0004
272 SYSTEMIC CANDIDA 1 0.0004
273 VASODILATATION 1 0.0004
274 BRAIN ABSCESS 1 0.0004
275 ABDOMINAL INFECTION 1 0.0004
276 CANCER PAIN 1 0.0004
277 PHYSICAL DECONDITIONING 1 0.0004
278 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
279 VENTRICULAR DYSFUNCTION 1 0.0004
280 MUCORMYCOSIS 1 0.0004
281 APLASTIC ANAEMIA 2 0.0004
282 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
283 RADICULOPATHY 1 0.0004
284 CONJUNCTIVITIS 7 0.0004
285 LEARNING DISABILITY 2 0.0004
286 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
287 SKIN DISCOMFORT 1 0.0004
288 TACHYPNOEA 5 0.0004
289 ENCEPHALOPATHY 9 0.0004
290 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
291 PLEURITIC PAIN 1 0.0004
292 HYPOMAGNESAEMIA 5 0.0004
293 ANAL HAEMORRHAGE 1 0.0004
294 PROCTITIS 1 0.0004
295 RESPIRATORY FAILURE 26 0.0004
296 PSEUDOMONAS INFECTION 3 0.0003
297 ANURIA 3 0.0003
298 PARAESTHESIA ORAL 5 0.0003
299 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
300 LUNG INFILTRATION 3 0.0003
301 INFUSION SITE REACTION 1 0.0003
302 METABOLIC ENCEPHALOPATHY 1 0.0003
303 HYPOAESTHESIA ORAL 5 0.0003
304 REBOUND ACID HYPERSECRETION 1 0.0003
305 EYELIDS PRURITUS 1 0.0003
306 RESPIRATORY RATE DECREASED 1 0.0003
307 PNEUMONIA VIRAL 1 0.0003
308 SKIN EROSION 1 0.0003
309 PORTAL VEIN THROMBOSIS 1 0.0003
310 LIVER ABSCESS 1 0.0003
311 THROMBOTIC MICROANGIOPATHY 3 0.0003
312 RENAL TUBULAR NECROSIS 3 0.0003
313 ASPERGILLUS INFECTION 2 0.0003
314 LISTLESS 1 0.0003
315 RENAL INJURY 9 0.0003
316 OLIGOHYDRAMNIOS 1 0.0003
317 BRONCHIECTASIS 2 0.0003
318 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
319 HEPATIC FUNCTION ABNORMAL 11 0.0003
320 WOUND COMPLICATION 1 0.0003
321 LEFT VENTRICULAR FAILURE 1 0.0003
322 RENAL IMPAIRMENT 24 0.0003
323 BRONCHIOLITIS 1 0.0003
324 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
325 LUNG TRANSPLANT 1 0.0003
326 BONE LESION 1 0.0003
327 DERMATITIS BULLOUS 2 0.0003
328 MONOCYTE COUNT INCREASED 1 0.0003
329 AMYLASE INCREASED 1 0.0003
330 CARDIAC DYSFUNCTION 1 0.0003
331 SKIN INFECTION 3 0.0003
332 HYDRONEPHROSIS 2 0.0003
333 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
334 CHRONIC SINUSITIS 1 0.0003
335 PROTEIN TOTAL DECREASED 1 0.0003
336 CATHETER SITE INFECTION 1 0.0003
337 ECONOMIC PROBLEM 4 0.0003
338 FACE INJURY 1 0.0003
339 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
340 ACUTE RESPIRATORY FAILURE 5 0.0003
341 PROCEDURAL HAEMORRHAGE 1 0.0003
342 RESPIRATORY ACIDOSIS 1 0.0003
343 RESPIRATORY ARREST 7 0.0003
344 BACTERAEMIA 3 0.0003
345 BLOOD ALBUMIN DECREASED 2 0.0003
346 PATENT DUCTUS ARTERIOSUS 1 0.0003
347 CEREBRAL ATROPHY 1 0.0003
348 CHRONIC KIDNEY DISEASE 19 0.0002
349 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
350 SKIN PAPILLOMA 1 0.0002
351 ORGAN FAILURE 1 0.0002
352 BONE MARROW FAILURE 5 0.0002
353 THERAPY NON-RESPONDER 11 0.0002
354 ESCHERICHIA INFECTION 2 0.0002
355 AORTIC DISSECTION 1 0.0002
356 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
357 COAGULOPATHY 4 0.0002
358 EOSINOPHIL COUNT INCREASED 2 0.0002
359 RHABDOMYOLYSIS 10 0.0002
360 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
361 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
362 POOR PERIPHERAL CIRCULATION 1 0.0002
363 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
364 OCULAR ICTERUS 1 0.0002
365 SPINAL OSTEOARTHRITIS 2 0.0002
366 HAEMORRHAGIC ANAEMIA 1 0.0002
367 GINGIVAL SWELLING 1 0.0002
368 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
369 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
370 CARDIOTOXICITY 2 0.0002
371 GASTROINTESTINAL INFECTION 2 0.0002
372 BLOOD BILIRUBIN INCREASED 6 0.0002
373 LEUKOCYTOSIS 4 0.0002
374 OPTIC NEURITIS 2 0.0002
375 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
376 SHOCK 5 0.0002
377 NEPHROGENIC ANAEMIA 1 0.0002
378 CARDIO-RESPIRATORY ARREST 9 0.0002
379 LYMPHOPENIA 3 0.0002
380 HYPOCALCAEMIA 4 0.0002
381 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
382 SINUS BRADYCARDIA 2 0.0002
383 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
384 BREATH SOUNDS ABNORMAL 1 0.0002
385 HAEMATOCRIT DECREASED 4 0.0002
386 IMMUNODEFICIENCY 3 0.0002
387 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
388 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
389 SEPSIS 22 0.0002
390 DRUG LEVEL DECREASED 2 0.0002
391 SUBARACHNOID HAEMORRHAGE 2 0.0002
392 CEREBRAL ISCHAEMIA 1 0.0002
393 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
394 ANAPHYLACTIC SHOCK 5 0.0002
395 VARICOSE VEIN 1 0.0002
396 PARTIAL SEIZURES 1 0.0002
397 SERUM FERRITIN INCREASED 1 0.0002
398 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
399 PNEUMOTHORAX 3 0.0002
400 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
401 PREMATURE DELIVERY 3 0.0002
402 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
403 ANAL ABSCESS 1 0.0002
404 DECREASED ACTIVITY 2 0.0002
405 CHEILITIS 1 0.0002
406 ERYTHEMA OF EYELID 1 0.0002
407 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
408 JAW DISORDER 1 0.0002
409 NONSPECIFIC REACTION 1 0.0002
410 PROSTATIC DISORDER 1 0.0002
411 NECROSIS 1 0.0002
412 BLOOD UREA INCREASED 3 0.0002
413 CANDIDA INFECTION 3 0.0002
414 EYE INFECTION 2 0.0002
415 SKIN TOXICITY 1 0.0002
416 PERIORBITAL SWELLING 1 0.0002
417 CARDIAC VALVE DISEASE 1 0.0002
418 VENTRICULAR SEPTAL DEFECT 1 0.0002
419 PERICARDIAL EFFUSION 4 0.0002
420 RALES 1 0.0002
421 SKIN WARM 1 0.0002
422 VASCULITIS 2 0.0002
423 BRADYKINESIA 1 0.0002
424 COVID-19 PNEUMONIA 2 0.0002
425 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
426 BLOOD CREATININE INCREASED 11 0.0002
427 PLEURISY 1 0.0002
428 FEBRILE NEUTROPENIA 11 0.0002
429 RENAL FAILURE 22 0.0002
430 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
431 C-REACTIVE PROTEIN INCREASED 6 0.0002
432 END STAGE RENAL DISEASE 3 0.0002
433 PIGMENTATION DISORDER 1 0.0002
434 GENERALISED OEDEMA 2 0.0002
435 CHOLANGITIS 1 0.0002
436 PHARYNGITIS 2 0.0002
437 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
438 HEPATIC CIRRHOSIS 3 0.0002
439 PHOTOPSIA 1 0.0002
440 METABOLIC ACIDOSIS 5 0.0002
441 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
442 PROCTALGIA 1 0.0002
443 PLATELET COUNT INCREASED 2 0.0002
444 POLYP 1 0.0002
445 ANHEDONIA 4 0.0002
446 ORAL CANDIDIASIS 2 0.0002
447 EAR INFECTION 4 0.0002
448 MENINGITIS 1 0.0001
449 BREAST MASS 1 0.0001
450 POSTOPERATIVE WOUND INFECTION 1 0.0001
451 ULCER HAEMORRHAGE 1 0.0001
452 EYE MOVEMENT DISORDER 1 0.0001
453 ECCHYMOSIS 1 0.0001
454 MENTAL STATUS CHANGES 4 0.0001
455 LARGE INTESTINE PERFORATION 1 0.0001
456 HYPERTRANSAMINASAEMIA 1 0.0001
457 DERMATITIS 3 0.0001
458 RIGHT VENTRICULAR FAILURE 1 0.0001
459 BLOOD TEST ABNORMAL 2 0.0001
460 PAPULE 1 0.0001
461 DUODENAL ULCER 1 0.0001
462 LEUKOPENIA 7 0.0001
463 MYELOSUPPRESSION 5 0.0001
464 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
465 MAJOR DEPRESSION 1 0.0001
466 THROMBOCYTOPENIA 15 0.0001
467 PANCREATITIS ACUTE 3 0.0001
468 HEPATIC ENZYME INCREASED 9 0.0001
469 TROPONIN INCREASED 1 0.0001
470 ACIDOSIS 1 0.0001
471 HYPOKALAEMIA 6 0.0001
472 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
473 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
474 APHTHOUS ULCER 1 0.0001
475 LUNG INFECTION 2 0.0001
476 EJECTION FRACTION DECREASED 2 0.0001
477 HYPOALBUMINAEMIA 1 0.0001
478 APNOEA 1 0.0001
479 PELVIC FRACTURE 1 0.0001
480 HAEMORRHAGIC STROKE 1 0.0001
481 GASTROINTESTINAL INFLAMMATION 1 0.0001
482 MULTIPLE ALLERGIES 1 0.0001
483 DRUG-INDUCED LIVER INJURY 4 0.0001
484 LOW BIRTH WEIGHT BABY 1 0.0001
485 GINGIVAL PAIN 1 0.0001
486 TRANSPLANT REJECTION 1 0.0001
487 POLYURIA 1 0.0001
488 ABNORMAL FAECES 1 0.0001
489 DRUG LEVEL INCREASED 2 0.0001
490 ATRIAL SEPTAL DEFECT 1 0.0001
491 RESPIRATORY TRACT INFECTION 3 0.0001
492 URINE OUTPUT DECREASED 1 0.0001
493 DRUG ERUPTION 2 0.0001
494 RESPIRATORY RATE INCREASED 1 0.0001
495 HAEMOLYTIC ANAEMIA 1 0.0001
496 DEVELOPMENTAL DELAY 1 0.0001
497 GASTROENTERITIS VIRAL 2 0.0001
498 OROPHARYNGEAL DISCOMFORT 1 0.0001
499 CARDIAC ARREST 9 0.0001
500 INCREASED TENDENCY TO BRUISE 1 0.0001
501 DEFORMITY 1 0.0001
502 DYSARTHRIA 4 0.0001
503 BLOOD PRESSURE DECREASED 7 0.0001
504 PROTEINURIA 2 0.0001
505 PNEUMONIA 34 0.0001
506 RED BLOOD CELL COUNT DECREASED 3 0.0001
507 EYE INFLAMMATION 1 0.0001
508 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
509 PRESCRIBED OVERDOSE 2 0.0001
510 PLATELET COUNT DECREASED 11 0.0001
511 OFF LABEL USE 90 0.0001
512 PHARYNGEAL SWELLING 1 0.0001
513 DRUG INEFFECTIVE 134 0.0001
514 HYPOTONIA 1 0.0001
515 BLOOD POTASSIUM DECREASED 3 0.0001
516 EMPHYSEMA 1 0.0001
517 VAGINAL DISCHARGE 1 0.0001
518 CONDITION AGGRAVATED 30 0.0001
519 EUPHORIC MOOD 1 0.0001
520 INITIAL INSOMNIA 1 0.0001
521 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
522 SKELETAL INJURY 1 0.0001
523 POOR VENOUS ACCESS 1 0.0001
524 PERITONITIS 2 0.0001
525 HYPERBILIRUBINAEMIA 1 0.0001
526 EYE DISCHARGE 1 0.0001
527 SKIN LACERATION 1 0.0001
528 OESOPHAGITIS 1 0.0001
529 TOOTH FRACTURE 1 0.0001
530 INFUSION RELATED REACTION 6 0.0001
531 DENTAL CARIES 1 0.0001
532 FOOT DEFORMITY 1 0.0001
533 STEVENS-JOHNSON SYNDROME 2 0.0001
534 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
535 HEPATOTOXICITY 2 0.0001
536 MALNUTRITION 1 0.0001
537 EYE PRURITUS 3 0.0001
538 OCULAR DISCOMFORT 1 0.0001
539 OXYGEN SATURATION DECREASED 5 0.0001
540 BLOOD CALCIUM DECREASED 1 0.0001
541 SCAB 1 0.0001
542 ELECTROLYTE IMBALANCE 1 0.0001
543 EYELID OEDEMA 1 0.0001
544 HYPOXIA 3 0.0001
545 BLOOD IRON DECREASED 1 0.0001
546 CATARACT 5 0.0001
547 CHOLECYSTITIS 1 0.0001
548 ACCIDENT 1 0.0001
549 POLYNEUROPATHY 1 0.0001
550 BURSITIS 1 0.0001
551 ADRENAL INSUFFICIENCY 1 0.0001
552 CEREBRAL INFARCTION 2 0.0001
553 LIVER INJURY 2 0.0001
554 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
555 CARDIOMEGALY 1 0.0001
556 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
557 ILEUS 1 0.0001
558 SECRETION DISCHARGE 1 0.0001
559 COVID-19 14 0.0001
560 DERMATITIS ALLERGIC 1 0.0001
561 INTRAOCULAR PRESSURE INCREASED 1 0.0001
562 INFUSION SITE PAIN 1 0.0001
563 PLASMA CELL MYELOMA 3 0.0001
564 DEAFNESS 2 0.0001
565 IMMUNE SYSTEM DISORDER 1 0.0001
566 JOINT RANGE OF MOTION DECREASED 1 0.0001
567 QUALITY OF LIFE DECREASED 1 0.0001
568 JAUNDICE 2 0.0001
569 SINUS CONGESTION 1 0.0001
570 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
571 NEUTROPHIL COUNT DECREASED 3 0.0001
572 PNEUMONITIS 2 0.0001
573 IMPAIRED GASTRIC EMPTYING 1 0.0001
574 AKATHISIA 1 0.0001
575 APPLICATION SITE RASH 1 0.0001
576 RESPIRATORY DISTRESS 2 0.0001
577 MEDICATION ERROR 4 0.0001
578 DEMENTIA 2 0.0001
579 CARPAL TUNNEL SYNDROME 1 0.0001
580 HYPONATRAEMIA 4 0.0001
581 SEASONAL ALLERGY 1 0.0001
582 INTENTIONAL DOSE OMISSION 2 0.0001
583 PARALYSIS 1 0.0001
584 HYPOTENSION 14 0.0001
585 HERPES ZOSTER 4 0.0001
586 MENTAL DISORDER 3 0.0001
587 FLUID OVERLOAD 1 0.0001
588 GASTROENTERITIS 1 0.0001
589 ACUTE MYOCARDIAL INFARCTION 2 0.0001
590 PULMONARY MASS 1 0.0001
591 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
592 HAEMORRHAGE INTRACRANIAL 1 0.0001
593 BONE LOSS 1 0.0001
594 PREMATURE BABY 2 0.0001
595 HEPATIC FAILURE 2 0.0001
596 LACRIMATION INCREASED 2 0.0001
597 STOMATITIS 4 0.0001
598 OSTEOPENIA 1 0.0001
599 NEPHROLITHIASIS 3 0.0001
600 INSURANCE ISSUE 1 0.0001
601 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
602 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
603 RENAL DISORDER 3 0.0001
604 THERAPY PARTIAL RESPONDER 1 0.0001
605 NERVOUS SYSTEM DISORDER 2 0.0001
606 OCULAR HYPERAEMIA 3 0.0001
607 ABSCESS 1 0.0001
608 MOVEMENT DISORDER 2 0.0001
609 LACTIC ACIDOSIS 2 0.0001
610 PRODUCT DOSE OMISSION 4 0.0001
611 EYE DISORDER 2 0.0001
612 HEART RATE INCREASED 6 0.0001
613 DRY EYE 3 0.0001
614 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
615 FACE OEDEMA 1 0.0001
616 SKIN EXFOLIATION 5 0.0001
617 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
618 CIRCULATORY COLLAPSE 1 0.0001
619 GASTRIC DISORDER 2 0.0001
620 MULTI-ORGAN FAILURE 1 0.0001
621 PYREXIA 20 0.0001
622 PARAESTHESIA 9 0.0001
623 HEART RATE DECREASED 2 0.0001
624 DERMATITIS ATOPIC 3 0.0001
625 LYMPHOCYTE COUNT DECREASED 1 0.0001
626 DRUG EFFECT DECREASED 3 0.0001
627 OEDEMA 3 0.0001
628 HYPERGLYCAEMIA 2 0.0001
629 EYE SWELLING 2 0.0001
630 PANCYTOPENIA 3 0.0001
631 BLISTER 3 0.0001
632 PHOTOPHOBIA 1 0.0001
633 BLOOD SODIUM DECREASED 1 0.0001
634 COLITIS 2 0.0001
635 GASTRIC ULCER 1 0.0001
636 DEHYDRATION 7 0.0001
637 FEELING JITTERY 1 0.0001
638 PULMONARY FIBROSIS 1 0.0001
639 ERUCTATION 1 0.0001
640 EAR PAIN 1 0.0001
641 ATRIAL FIBRILLATION 5 0.0001
642 SINUS DISORDER 1 0.0001
643 DISORIENTATION 2 0.0001
644 RASH 22 0.0001
645 DRUG INTERACTION 8 0.0001
646 UPPER LIMB FRACTURE 1 0.0001
647 PRESCRIBED UNDERDOSE 1 0.0001
648 SPINAL FRACTURE 1 0.0000
649 CYTOKINE RELEASE SYNDROME 1 0.0000
650 FULL BLOOD COUNT DECREASED 1 0.0000
651 PLEURAL EFFUSION 3 0.0000
652 BODY TEMPERATURE INCREASED 1 0.0000
653 HAEMOGLOBIN DECREASED 5 0.0000
654 OSTEOPOROSIS 2 0.0000
655 INJECTION SITE WARMTH 1 0.0000
656 RIB FRACTURE 1 0.0000
657 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
658 TOOTH LOSS 1 0.0000
659 PULMONARY HYPERTENSION 1 0.0000
660 ROAD TRAFFIC ACCIDENT 2 0.0000
661 TOXICITY TO VARIOUS AGENTS 8 0.0000
662 HALLUCINATION, VISUAL 1 0.0000
663 RENAL FAILURE ACUTE 2 0.0000
664 POOR QUALITY SLEEP 1 0.0000
665 PRURITUS GENERALISED 1 0.0000
666 FAECES DISCOLOURED 1 0.0000
667 MELAENA 1 0.0000
668 TACHYCARDIA 4 0.0000
669 TOOTH DISORDER 1 0.0000
670 RASH MACULO-PAPULAR 1 0.0000
671 INFLUENZA 5 0.0000
672 GLOSSODYNIA 1 0.0000
673 ORAL PAIN 1 0.0000
674 GASTROINTESTINAL DISORDER 4 0.0000
675 PRODUCT AVAILABILITY ISSUE 1 0.0000
676 SKIN DISCOLOURATION 2 0.0000
677 SEIZURE 5 0.0000
678 DISEASE PROGRESSION 5 0.0000
679 DISEASE RECURRENCE 2 0.0000
680 ANAEMIA 8 0.0000
681 RASH ERYTHEMATOUS 2 0.0000
682 DIABETIC KETOACIDOSIS 1 0.0000
683 DRUG INTOLERANCE 4 0.0000
684 INTERSTITIAL LUNG DISEASE 2 0.0000
685 FIBROMYALGIA 1 0.0000
686 URINARY TRACT INFECTION 7 0.0000
687 BRONCHITIS 3 0.0000
688 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
689 ABDOMINAL PAIN LOWER 1 0.0000
690 UNRESPONSIVE TO STIMULI 1 0.0000
691 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
692 ECZEMA 2 0.0000
693 MUCOSAL INFLAMMATION 1 0.0000
694 JOINT STIFFNESS 1 0.0000
695 BRADYCARDIA 2 0.0000
696 CARDIAC FAILURE 3 0.0000
697 THROMBOSIS 3 0.0000
698 PAIN OF SKIN 1 0.0000
699 FREQUENT BOWEL MOVEMENTS 1 0.0000
700 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
701 NEUTROPENIA 5 0.0000
702 MOOD ALTERED 1 0.0000
703 ABNORMAL DREAMS 1 0.0000
704 ANAPHYLACTIC REACTION 2 0.0000
705 TREMOR 6 0.0000
706 DIVERTICULITIS 1 0.0000
707 PROCEDURAL PAIN 1 0.0000
708 EYE PAIN 2 0.0000
709 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
710 FLATULENCE 2 0.0000
711 RHEUMATOID ARTHRITIS 4 0.0000
712 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
713 CHILLS 4 0.0000
714 ASCITES 1 0.0000
715 LABORATORY TEST ABNORMAL 1 0.0000
716 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
717 RESPIRATORY DISORDER 1 0.0000
718 EMOTIONAL DISTRESS 4 0.0000
719 CORONARY ARTERY DISEASE 1 0.0000
720 EXPOSURE DURING PREGNANCY 2 0.0000
721 BONE DENSITY DECREASED 1 0.0000
722 ANXIETY 9 0.0000
723 HEAD INJURY 1 0.0000
724 CYSTITIS 1 0.0000
725 DEATH 27 0.0000
726 HYPOTHYROIDISM 1 0.0000
727 DEEP VEIN THROMBOSIS 2 0.0000
728 PSORIASIS 4 0.0000
729 IMPAIRED HEALING 1 0.0000
730 STAPHYLOCOCCAL INFECTION 1 0.0000
731 BACK PAIN 7 0.0000
732 VIRAL INFECTION 1 0.0000
733 LIP SWELLING 1 0.0000
734 SYNCOPE 3 0.0000
735 URINARY RETENTION 1 0.0000
736 HAEMATURIA 1 0.0000
737 DELIRIUM 1 0.0000
738 NEOPLASM PROGRESSION 1 0.0000
739 WEIGHT DECREASED 8 0.0000
740 RASH MACULAR 1 0.0000
741 BURNING SENSATION 2 0.0000
742 HYPERTENSION 6 0.0000
743 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
744 PRODUCT ADHESION ISSUE 1 0.0000
745 INFECTION 4 0.0000
746 CRYING 1 0.0000
747 PANIC ATTACK 1 0.0000
748 PRODUCT DOSE OMISSION ISSUE 8 0.0000
749 HYPERSENSITIVITY 5 0.0000
750 DYSGEUSIA 2 0.0000
751 HYPOAESTHESIA 4 0.0000
752 DYSPNOEA EXERTIONAL 1 0.0000
753 HALLUCINATION 2 0.0000
754 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
755 PRURITUS 10 0.0000
756 VOMITING 12 0.0000
757 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
758 ABORTION SPONTANEOUS 1 0.0000
759 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
760 DYSPNOEA 14 0.0000
761 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
762 PSORIATIC ARTHROPATHY 1 0.0000
763 ERYTHEMA 5 0.0000
764 VISUAL IMPAIRMENT 3 0.0000
765 COMPLETED SUICIDE 2 0.0000
766 CEREBROVASCULAR ACCIDENT 4 0.0000
767 RECTAL HAEMORRHAGE 1 0.0000
768 DIARRHOEA 15 0.0000
769 HYPOACUSIS 1 0.0000
770 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
771 LIVER DISORDER 1 0.0000
772 COLITIS ULCERATIVE 1 0.0000
773 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
774 TINNITUS 1 0.0000
775 BLOOD CHOLESTEROL INCREASED 1 0.0000
776 COGNITIVE DISORDER 1 0.0000
777 SWELLING 2 0.0000
778 ASTHENIA 8 0.0000
779 ARRHYTHMIA 1 0.0000
780 DYSPHAGIA 2 0.0000
781 PULMONARY EMBOLISM 2 0.0000
782 FALL 7 0.0000
783 PRODUCTIVE COUGH 1 0.0000
784 CONTUSION 2 0.0000
785 HYPOGLYCAEMIA 1 0.0000
786 LUNG DISORDER 1 0.0000
787 ALOPECIA 4 0.0000
788 ABDOMINAL PAIN UPPER 4 0.0000
789 INFLAMMATION 1 0.0000
790 FATIGUE 15 0.0000
791 HAEMORRHAGE 2 0.0000
792 NAUSEA 15 0.0000
793 PANCREATITIS 1 0.0000
794 DEPRESSED MOOD 1 0.0000
795 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
796 DRUG DEPENDENCE 3 0.0000
797 RASH PRURITIC 1 0.0000
798 HAEMATOCHEZIA 1 0.0000
799 PAIN 11 0.0000
800 MUSCULAR WEAKNESS 2 0.0000
801 DEPRESSION 4 0.0000
802 CONVULSION 1 0.0000
803 LETHARGY 1 0.0000
804 EYE IRRITATION 1 0.0000
805 PRODUCT SUBSTITUTION ISSUE 1 0.0000
806 ABDOMINAL PAIN 4 0.0000
807 BONE PAIN 1 0.0000
808 NASAL CONGESTION 1 0.0000
809 WHEEZING 1 0.0000
810 JOINT SWELLING 2 0.0000
811 NO ADVERSE EVENT 3 0.0000
812 OEDEMA PERIPHERAL 2 0.0000
813 VERTIGO 1 0.0000
814 DIZZINESS 8 0.0000
815 LOSS OF CONSCIOUSNESS 2 0.0000
816 AMNESIA 1 0.0000
817 SWELLING FACE 1 0.0000
818 DRY SKIN 2 0.0000
819 NEOPLASM MALIGNANT 1 0.0000
820 INJECTION SITE PRURITUS 1 0.0000
821 SOMNOLENCE 3 0.0000
822 VISION BLURRED 2 0.0000
823 INJECTION SITE REACTION 1 0.0000
824 COUGH 4 0.0000
825 INJURY 1 0.0000
826 SLEEP DISORDER 1 0.0000
827 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
828 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
829 THERAPY INTERRUPTED 1 0.0000
830 SKIN BURNING SENSATION 1 0.0000
831 CONSTIPATION 3 0.0000
832 MALAISE 6 0.0000
833 UNEVALUABLE EVENT 1 0.0000
834 INCORRECT DOSE ADMINISTERED 3 0.0000
835 DIABETES MELLITUS 1 0.0000
836 INJECTION SITE SWELLING 1 0.0000
837 PERIPHERAL SWELLING 2 0.0000
838 HEADACHE 8 0.0000
839 INJECTION SITE BRUISING 1 0.0000
840 CARDIAC FAILURE CONGESTIVE 1 0.0000
841 DRY MOUTH 1 0.0000
842 DRUG DOSE OMISSION 2 0.0000
843 DRUG ABUSE 1 0.0000
844 URTICARIA 2 0.0000
845 BALANCE DISORDER 1 0.0000
846 INTENTIONAL PRODUCT MISUSE 1 0.0000
847 MUSCULOSKELETAL STIFFNESS 1 0.0000
848 INSOMNIA 3 0.0000
849 ADVERSE DRUG REACTION 1 0.0000
850 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
851 CHEST PAIN 2 0.0000
852 BREAST CANCER 1 0.0000
853 CARDIAC DISORDER 1 0.0000
854 BLOOD GLUCOSE INCREASED 2 0.0000
855 NEUROPATHY PERIPHERAL 1 0.0000
856 GAIT DISTURBANCE 2 0.0000
857 PAIN IN EXTREMITY 3 0.0000
858 DYSPEPSIA 1 0.0000
859 FLUSHING 1 0.0000
860 CHEST DISCOMFORT 1 0.0000
861 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
862 SINUSITIS 1 0.0000
863 ILLNESS 1 0.0000
864 ARTHRALGIA 4 0.0000
865 OVERDOSE 2 0.0000
866 WEIGHT INCREASED 2 0.0000
867 ASTHMA 1 0.0000
868 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
869 DECREASED APPETITE 2 0.0000
870 INJECTION SITE ERYTHEMA 1 0.0000
871 HYPERHIDROSIS 1 0.0000
872 MEMORY IMPAIRMENT 1 0.0000
873 ABDOMINAL DISCOMFORT 1 0.0000
874 MUSCLE SPASMS 1 0.0000
875 NASOPHARYNGITIS 1 0.0000
876 PRODUCT USE ISSUE 1 0.0000
877 FEELING ABNORMAL 1 0.0000